In addition, several serum protein tumor markers are associated with and adopted in breast cancer management, especially cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) [6], as well as soluble HER2 [7]. Here, CEACAM5 is linked to breast cancer.